Erythema multiforme secondary to the use of carbamazepine during pregnancy: report of a patient

Authors

  • Juan Carlos Ojeda Blanco Hospital Ginecoobstetrico “Mariana Grajales”, Santa Clara, Villa Clara
  • Juan Antonio Suarez González Hospital Ginecoobstetrico “Mariana Grajales”, Santa Clara, Villa Clara
  • Mario Gutiérrez Machado Hospital Ginecoobstetrico “Mariana Grajales”, Santa Clara, Villa Clara

Keywords:

erythema multiforme, carbamazepine, pregnancy

Abstract

Drug-induced skin disorders cause very different clinical symptoms in the skin that sometimes mimic well-defined dermatologic diseases and cause confusion with them. The immediate elimination of the drug is essential to the management of these patients. It is reported the case of a drug-induced skin disorder secondary to the use of carbamazepine in a 29.3-week-pregnant woman who attended the Internal Medicine Consultation due to a maculopapular rash that was generalized to encompass 90% of the skin surface. The patient progressed satisfactorily after discontinuing the anticonvulsant treatment; dermatological symptoms disappeared.

 


Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Ojeda Blanco JC, Suarez González JA, Gutiérrez Machado M. Erythema multiforme secondary to the use of carbamazepine during pregnancy: report of a patient. Acta Méd Centro [Internet]. 2013 Oct. 7 [cited 2025 Jun. 27];7(3):56-60. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/9

Issue

Vol. 7 No. 3 (2013): July-September

Section

Case Reports

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).